SCHEMBL23837290

SCHEMBL23837290

O=NB1Oc2c(cccc2C(=O)O)C[C@@H]1NC(=O)CCc1cocn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17337190 0.88 CYP2C8 (0.30) —
SCHEMBL17337187 0.88 CYP2C8 (0.30) —
SCHEMBL23837330 0.79 PARP1 (0.30) —
SCHEMBL23837340 0.77 HPGD (0.33) —
SCHEMBL23837318 0.77 ACLY (0.30) —
SCHEMBL23837447 0.77 MAPT (0.32) —
SCHEMBL23837322 0.77 MTNR1A (0.32) —
SCHEMBL21698374 0.71 PARP1 (0.32) —
SCHEMBL21698406 0.70 — —
SCHEMBL18797959 0.69 SMYD3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback